Navigation Links
Biophysical Society announces 2008 International Travel Awards
Date:12/21/2007

gic Modulation of the Intermolecular Signaling Between a Single L-type Ca2+ Channel and Ryanodine Receptors in Rat Heart Cells.

  • Xu-Long Wang, Shanghai Jiao Tong University, China, Intracellular Calcium Dynamics Mediated by NMDA Receptors in Retinal Horizontal Cells.

  • Merridee A. Wouters, Victor Chang Cardiac Research Institute, Sydney, Australia, 'Forbidden' Disulfides: Their Role as Redox Switches.

  • Rong Xia, Institute of Membrane and System Biology, Leeds, United Kingdom, Role of the Conserved Asp987 Residue in the Ca2+ Permeation of hTRPM2 Channel.

  • Junichiro Yajima, Gakushuin University, Tokyo, Japan, Microtubule Sliding and Rotation Driven by Single-Headed Kinesins. Alexandra Zahradnikova, Jr., Institute of Molecular Physiology and Genetics, Bratislava, Slovakia, Low Amplitude of Late Ca2+ Spikes is a Result of Decreased Calcium Release Flux.


'/>"/>

Contact: Ellen R. Weiss
eweiss@biophysics.org
301-634-7176
Biophysical Society
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology news :

1. Media highlights in the November issues of Biophysical Journal
2. Roger Kornberg to present lecture at the Joint Biophysical Society/IUPAB Meeting
3. Media highlights in the Dec. 15 issue of Biophysical Journal
4. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
5. Tips from the Journals of the American Society for Microbiology
6. American Chemical Societys Weekly PressPac -- Aug. 15, 2007
7. American Chemical Societys Weekly Press Pac
8. Society for General Microbiology 161st Meeting, University of Edinburgh
9. American Chemical Societys Weekly Presspac -- Aug. 29, 2007
10. American Chemical Society calls green chemistry bill a smart step
11. The American Society of Plant Biologists announces 2007 awards
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2